Search Results

Filter
  • 1-10 of  838,511 results for ""ANTINEOPLASTIC agents""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents-updated MASCC/ESMO consensus recommendation.

  • Authors : Jordan K; Department of Hematology, Oncology and Palliative Medicine, Ernst von Bergmann Hospital Potsdam, Charlottenstraße 72, 14467, Potsdam, Germany. .; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany. .

Subjects: Antiemetics*/Antiemetics*/Antiemetics*/therapeutic use ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects; Humans

  • Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Dec 22; Vol. 32 (1), pp. 53. Date of Electronic Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents.

  • Authors : Scotté F; Interdisciplinary Patient Pathway Division, Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. .; Schwartzberg L

Subjects: Antiemetics*/Antiemetics*/Antiemetics*/therapeutic use ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects; Humans

  • Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Dec 20; Vol. 32 (1), pp. 45. Date of Electronic Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents.

  • Authors : Herrstedt J; Department of Clinical Oncology, Zealand University Hospital, Sygehusvej 10, DK-4000, Roskilde, Denmark. .; Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. .

Subjects: Antiemetics*/Antiemetics*/Antiemetics*/therapeutic use ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects; Female

  • Source: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2023 Dec 21; Vol. 32 (1), pp. 47. Date of Electronic Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

ACEI/ARB and beta-blocker therapies for preventing cardiotoxicity of antineoplastic agents in breast cancer: a systematic review and meta-analysis.

  • Authors : Gao Y; College of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029, China.; Wang R

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy; Humans

  • Source: Heart failure reviews [Heart Fail Rev] 2023 Nov; Vol. 28 (6), pp. 1405-1415. Date of Electronic Publication: 2023 Jul 07.Publisher: Kluwer Academic Publishers Country of Publication: United States NLM ID: 9612481 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

A chloromethyl-triazole fluorescent chemosensor for O 6 -methylguanine DNA methyltransferase.

  • Authors : Ayan S; Department of Chemical and Physical Sciences, University of Toronto Mississauga, Mississauga, Ontario, L5L 1C6, Canada. .; Rotaru AM

Subjects: Antineoplastic Agents*; Guanine/Guanine/Guanine/*analogs & derivatives; Temozolomide

  • Source: Organic & biomolecular chemistry [Org Biomol Chem] 2024 Apr 03; Vol. 22 (14), pp. 2749-2753. Date of Electronic Publication: 2024 Apr 03.Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101154995 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Anti-tumor activity of selinexor in combination with antineoplastic agents in chronic lymphocytic leukemia.

  • Authors : Vitale C; University Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino, 10126, Turin, Italy.; Department of Molecular Biotechnology and Health Sciences, University of Torino, 10126, Turin, Italy.

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/pathology ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

  • Source: Scientific reports [Sci Rep] 2023 Oct 07; Vol. 13 (1), pp. 16950. Date of Electronic Publication: 2023 Oct 07.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cancer-associated thrombosis and drug-drug interactions of antithrombotic and antineoplastic agents.

  • Authors : Bolek H; Department of Medical Oncology, Ankara University School of Medicine, Ankara, Turkey.; Ankara University Cancer Research Institute, Ankara, Turkey.

Subjects: Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/epidemiology ; Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/etiology ; Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/prevention & control

  • Source: Cancer [Cancer] 2023 Oct 15; Vol. 129 (20), pp. 3216-3229. Date of Electronic Publication: 2023 Jul 04.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details

×
Academic Journal

Influence of occupational exposure to antineoplastic agents on adverse pregnancy outcomes among nurses: A meta-analysis.

  • Authors : Liu S; Clinical Medical College of Shenzhen, Guangzhou University of Chinese Medicine, Shenzhen, China.; Huang Y

Subjects: Occupational Exposure*/Occupational Exposure*/Occupational Exposure*/adverse effects ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/adverse effects ; Nurses*

  • Source: Nursing open [Nurs Open] 2023 Sep; Vol. 10 (9), pp. 5827-5837. Date of Electronic Publication: 2023 May 23.Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101675107 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Synergistic effect of cryptotanshinone and temozolomide treatment against human glioblastoma cells.

  • Authors : Zhu S; Brain Research Institute, Research Center of Neurological Diseases, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Rd, Shiyan, 442000, Hubei, China.; Guo J

Subjects: Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/genetics

  • Source: Scientific reports [Sci Rep] 2023 Dec 09; Vol. 13 (1), pp. 21835. Date of Electronic Publication: 2023 Dec 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Magnetic Resonance Imaging of Iron Metabolism with T2* Mapping Predicts an Enhanced Clinical Response to Pharmacologic Ascorbate in Patients with GBM.

  • Authors : Petronek MS; Department of Radiation Oncology, University of Iowa, Iowa City, Iowa.; Monga V

Subjects: Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use ; Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/drug therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/diagnostic imaging

  • Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 17; Vol. 30 (2), pp. 283-293.Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265

Record details

×
  • 1-10 of  838,511 results for ""ANTINEOPLASTIC agents""